SCHEMBL14015153

SCHEMBL14015153

O=C(O)c1cc(-c2ccc(CN(Cc3ccc(F)cc3)C(=O)c3ccc4c(c3)OCO4)cc2)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.49
GABRB2 P47870 1/20 0.49
HTR5A P47898 1/20 0.47
HPGD P15428 3/20 0.47
ALDH1A1 P00352 3/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46
PPARA Q07869 1/20 0.44
STING1 Q86WV6 1/20 0.44
CTNNB1 P35222 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2412849 0.92 HPGD (0.56) GABRA1GABRB2HTR5AHPGDALDH1A1
SCHEMBL2410847 0.90 GABRA1 (0.52) GABRA1GABRB2HTR5AHPGDALDH1A1
SCHEMBL2410446 0.88 RAB9A (0.51) GABRA1GABRB2HPGDALDH1A1TSHR
SCHEMBL2416620 0.87 GABRA1 (0.47) GABRA1GABRB2HTR5AHPGDALDH1A1
SCHEMBL2414417 0.86 HPGD (0.52) GABRA1GABRB2HTR5AHPGDALDH1A1
SCHEMBL2413110 0.86 GABRA1 (0.47) GABRA1GABRB2HTR5AHPGDALDH1A1
SCHEMBL2408990 0.85 HPGD (0.56) GABRA1GABRB2HPGDALDH1A1
SCHEMBL2415459 0.82 STAT3 (0.51) HPGDALDH1A1USP2PPARASTING1
SCHEMBL2413423 0.81 NPC1 (0.48) GABRA1GABRB2HPGDALDH1A1USP2
SCHEMBL2412850 0.78 HPGD (0.53) GABRA1GABRB2HTR5AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7453009-B2 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-11-18 US disclosed
US-7453009-B2 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-11-18 US disclosed
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-01-31 US disclosed
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE GPR119, HACL2, HCAR2 GABRA1 955/4885GABRB2 394/4885HTR5A 1873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.